Overview

Efficacy of Rivastigmine in Patients With Down Syndrome

Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
This study is to understand the efficacy on language and cognitive function in Down syndrome patients who take Rivastigmine.
Phase:
N/A
Details
Lead Sponsor:
National Taiwan University Hospital
Treatments:
Cholinesterase Inhibitors
Rivastigmine